<DOC>
	<DOCNO>NCT01984320</DOCNO>
	<brief_summary>The effectiveness cabergoline prevent moderate-severe OHSS coasting .</brief_summary>
	<brief_title>Cabergoline Coasting Prevent OHSS</brief_title>
	<detailed_description>To randomly compare three study group high risk develop OHSS one three arm management , either coast 1 3 day receive cabergoline 8 day coast 1 day plus receive cabergoline 8 day ICSI patient follow long luteal GnRH agonist protocol .</detailed_description>
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<mesh_term>Cabergoline</mesh_term>
	<mesh_term>Menotropins</mesh_term>
	<criteria>1 . Age &lt; or= 35 , BMI &lt; or= 30 2 . Long protocol GnRH agonist cycle 3 . Estradiol level day HCG &gt; or= 3500 pg/ml 4 . Retrieving 15 oocyte 1 . Male factor 2 . Uterine factor</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>OHSS</keyword>
	<keyword>ICSI</keyword>
	<keyword>Coasting</keyword>
	<keyword>Cabergoline</keyword>
</DOC>